LAPIX Therapeutics
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
271 Cambridge St Fl 2, Cambridge, Massac...Website
www.lapix.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About LAPIX Therapeutics
LAPIX Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative, orally bioavailable therapies for autoimmune diseases and oncology. Their patient-centric approach aims to restore immune balance through non-immunosuppressive treatments that target the root causes of autoimmune conditions. The company specializes in antigen-agnostic immune tolerance restoration therapies, particularly utilizing TIM (T-cell immunoglobulin and mucin domain) agonists to regulate immune responses. LAPIX is dedicated to transforming the treatment landscape for patients suffering from autoimmune diseases such as Multiple Sclerosis, Rheumatoid Arthritis, and Crohn's Disease.Explore more
LAPIX Therapeutics Org Chart
BK
Associate Director, Formulation Development &...
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is LAPIX Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when LAPIX Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at LAPIX Therapeutics
Funding: Get notified immidiatlly once LAPIX Therapeutics has new funding data
Click to see if LAPIX Therapeutics had a recent Job posting/layoffs
Check if LAPIX Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if LAPIX Therapeutics is spiking on competitors!
LAPIX Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on LAPIX Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at LAPIX Therapeutics
Find more new buyers
Compare Similar Companies to LAPIX Therapeutics
Compare insights from companies similar to LAPIX Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
LAPIX Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
LAPIX Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about LAPIX Therapeutics.
LAPIX Therapeutics Tech Stack
A closer look at the technologies used by LAPIX Therapeutics
LAPIX Therapeutics News & Media
LAPIX Therapeutics Doses First Patient-In Phase 1b Clinical Trial of LPX-TI641 for Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA)
CAMBRIDGE, Mass., Jan. 23, 2025 (GLOBE NEWSWIRE) -- LAPIX Therapeutics, Inc. (“LAPIX”), a clinical-stage biopharmaceutical company focused on developing novel, orally bioavailable immune system restoration therapies for autoimmune diseases based on agonism of TIM (T cell/transmembrane, immunoglobulin, and mucin receptor), today announced the dosing of first subject with its investigational medicine, LPX-TI641, in its Phase 1b clinical trial (NCT06628206). The Phase 1b trial is a randomized, doubLAPIX Therapeutics Announces Positive Topline Phase 1 Clinical Data Results with LPX-TI641 for the Treatment of Autoimmune Diseases
BOSTON, Nov. 20, 2024 (GLOBE NEWSWIRE) -- LAPIX Therapeutics, Inc. (“LAPIX”), a clinical-stage biopharmaceutical company focused on developing novel, orally bioavailable immune system restoration therapies for autoimmune diseases based on agonism of TIM (T cell/transmembrane, immunoglobulin, and mucin receptor), today announced positive topline results from its Phase I randomized, double-blind, placebo-controlled single and multiple-ascending dose (SAD and MAD) trial to assess the safety, tolera
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding LAPIX Therapeutics
Sign Up For FreeTo access detailed company insights
LAPIX Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative, orally bioavailable therapies for autoimmune diseases and oncology. Their patient-centric approach aims to restore immune balance through non-immunosuppressive treatments that target the root causes of autoimmune conditions. The company specializes in... Read More
